使用Player FM应用程序离线!
Trends and Innovations in Orthopaedics: A CEO’s Perspective With Guest Cheryl Blanchard, PhD
Manage episode 342715056 series 2903350
Trends and Innovations in Orthopaedics: A CEO’s Perspective
Hosts Charles A. Goldfarb, MD, FAOA and Alexander Aleem, MD sit down with Cheryl Blanchard, BS, MS, PhD, president and CEO of Anika Therapeutics, to discuss how the company is driving technological innovations to benefit patients, orthopaedic surgeons, payors, and health care organizations.
Dr. Blanchard discusses how new orthopaedic trends impact the development process and shape product offerings. She describes how the 2020 acquisitions of Arthrosurface and Parcus Medical have dramatically shortened Anika’s innovation cycles to deliver greater value to physicians, patients, and shareholders.
The conversation touches on Dr. Blanchard’s career journey, merging her expertise in medicine, engineering, and business to becoming a leader of a multi-national orthopaedics corporation. She provides perspectives on challenging yourself professionally, including experiencing new things and not being afraid to accept a challenge.
Dr. Blanchard assumed the role of Anika’s president and chief executive officer in April 2020. She has served as president and CEO of Microchips Biotech, held senior executive positions at Zimmer-Biotech, and provided strategic consulting services to medical device companies and private equity clients. Dr. Blanchard currently serves as director of Vigil Neuroscience and Daré Bioscience. Dr. Blanchard received her M.S. and Ph.D. in Materials Science and Engineering from the University of Texas at Austin and received her B.S. in Ceramic Engineering from Alfred University.
Anika (NASDAQ: ANIK) is a global joint preservation company committed to delivering meaningful advancements in early intervention orthopedic care, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies.
47集单集
Manage episode 342715056 series 2903350
Trends and Innovations in Orthopaedics: A CEO’s Perspective
Hosts Charles A. Goldfarb, MD, FAOA and Alexander Aleem, MD sit down with Cheryl Blanchard, BS, MS, PhD, president and CEO of Anika Therapeutics, to discuss how the company is driving technological innovations to benefit patients, orthopaedic surgeons, payors, and health care organizations.
Dr. Blanchard discusses how new orthopaedic trends impact the development process and shape product offerings. She describes how the 2020 acquisitions of Arthrosurface and Parcus Medical have dramatically shortened Anika’s innovation cycles to deliver greater value to physicians, patients, and shareholders.
The conversation touches on Dr. Blanchard’s career journey, merging her expertise in medicine, engineering, and business to becoming a leader of a multi-national orthopaedics corporation. She provides perspectives on challenging yourself professionally, including experiencing new things and not being afraid to accept a challenge.
Dr. Blanchard assumed the role of Anika’s president and chief executive officer in April 2020. She has served as president and CEO of Microchips Biotech, held senior executive positions at Zimmer-Biotech, and provided strategic consulting services to medical device companies and private equity clients. Dr. Blanchard currently serves as director of Vigil Neuroscience and Daré Bioscience. Dr. Blanchard received her M.S. and Ph.D. in Materials Science and Engineering from the University of Texas at Austin and received her B.S. in Ceramic Engineering from Alfred University.
Anika (NASDAQ: ANIK) is a global joint preservation company committed to delivering meaningful advancements in early intervention orthopedic care, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies.
47集单集
Todos os episódios
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。